abrdn Life Sciences Investors — Proxy Solicitation & Information Statement 2012

Jun 4, 2012

DEFA14A 1 a12-13579_1defa14a.htm DEFA14A

		SECURITIES AND EXCHANGE COMMISSION
		Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant x
Filed by a Party other than the Registrant o
Check the appropriate box:
o	Preliminary Proxy Statement
o	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o	Definitive Proxy Statement
x	Definitive Additional Materials
o	Soliciting Material Pursuant to §240.14a-12
H&Q Life Sciences Investors
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
x	No fee required.
o	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
	(1)	Title of each class of securities to which transaction applies:
	(2)	Aggregate number of securities to which transaction applies:
	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
	(4)	Proposed maximum aggregate value of transaction:
	(5)	Total fee paid:
o	Fee paid previously with preliminary materials.
o	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
	(1)	Amount Previously Paid:
	(2)	Form, Schedule or Registration Statement No.:
	(3)	Filing Party:
	(4)	Date Filed:

SEQ.=1,FOLIO='',FILE='C:\JMS\106747\12-13579-1\task5383146\13579-1-ba.htm',USER='106747',CD='Jun 2 21:15 2012'

**Shareholder Services****

June 4, 2012

*URGENT MATTER*

Re: *H&Q Life Sciences Investors*

Dear Shareholder,

We have been trying to get in touch with you regarding a very important matter pertaining to your investment in the H&Q Life Sciences Investors. This matter pertains to important operating business for the fund.

It is very important that we speak to you regarding this matter. Please call toll-free 1-877 *- 864-5054 extension 7573* between 9:00 a.m. and 10:00 p.m. EST Monday through Friday. We do not require you to provide any account information when calling.

Sincerely,

Frederick M. Bonnell

Managing Director

Shareholder Services

TAGID: 0000123

AST Fund Solutions · 1200 Wall Street West, 3 rd Floor · Lyndhurst, NJ 07071

SEQ.=1,FOLIO='',FILE='C:\JMS\brama\12-13579-1\task5383270\13579-1-bc.htm',USER='105435',CD='Jun 3 08:22 2012'